ARCHIVES

Studies Link Age-Dependent Outcome To Immune Cells

This article is from The Cancer Letter archive.

Vol. 26 No. 11 | November 28, 2003

Download PDF Visit The Full Archive

Related Articles

Pittsburgh Reprimands Staff For Use of Univ. Resources In Mailing

May 13, 1994

Cediranib/Olaparib Combination Nearly Doubles PFS in Phase II

September 26, 2014

Scientists, advocates voice objections to von Eschenbach’s conflicts, 2015.

November 23, 2005

ACS Says 41 Percent Survive 5 Years

January 2, 1981

ONS To Fund 21 Grants In ’94 Deadline Dec. 1

June 11, 1993

As ImClone Investigation Continues, FDA Combines Drugs, Biologics Review; Memo Describes “Lengthy Process” That Led To FDA Decision; Oncology Community Praises FDA Move

September 13, 2002